BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 11391940)

  • 1. [Molecular markers for the blood coagulation and fibrinolysis].
    Okajima K
    Rinsho Byori; 2001 Mar; Suppl 115():74-90. PubMed ID: 11391940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dynamics of blood coagulation and fibrinolysis and laboratory findings in disseminated intravascular coagulation].
    Madoiwa S
    Rinsho Ketsueki; 2010 Jan; 51(1):20-8. PubMed ID: 20134136
    [No Abstract]   [Full Text] [Related]  

  • 4. Soluble fibrin as a molecular marker for a pre-thrombotic state: a mini-review.
    Nieuwenhuizen W
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):93-6. PubMed ID: 8457659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Application of hemostatic molecular markers for diagnosis of thrombosis].
    Wada H; Sakakura M; Nobori T; Shiku H
    Rinsho Byori; 2000 Apr; 48(4):301-7. PubMed ID: 10810874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical application of fibrinolysis laboratory tests: a review.
    Prisco D; Conti AA; Giurlani L; Falciani M
    Ann Ital Med Int; 1998; 13(2):81-7. PubMed ID: 9734140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are fibrin-related markers useful for the diagnosis of thrombosis?
    Wada H; Sakuragawa N
    Semin Thromb Hemost; 2008 Feb; 34(1):33-8. PubMed ID: 18393141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
    Colick JA; Fisher LM
    Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992
    [No Abstract]   [Full Text] [Related]  

  • 9. Simultaneous determination of coagulation and fibrinolysis parameters for diagnostics of disseminated intravascular blood coagulation (DIC).
    Lezhen T; Kramarev S; Kolesnik L; Kudinov S
    Mater Med Pol; 1992; 24(2):79-81. PubMed ID: 1307773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of ethanol and protamine tests in demonstration of soluble fibrin and early products of fibrin degradation.
    Konttinen YP; Kemppainen L; Turunen O
    Thromb Diath Haemorrh; 1972 Dec; 28(3):342-50. PubMed ID: 4675265
    [No Abstract]   [Full Text] [Related]  

  • 11. Disseminated intravascular coagulation and a negative D-dimer test.
    Constantinescu AA; Berendes PB; Levin MD
    Neth J Med; 2007 Nov; 65(10):398-400. PubMed ID: 18057464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and prognosis of overt disseminated intravascular coagulation in a general hospital -- meaning of the ISTH score system, fibrin monomers, and lipoprotein-C-reactive protein complex formation.
    Cauchie P; Cauchie Ch; Boudjeltia KZ; Carlier E; Deschepper N; Govaerts D; Migaud-Fressart M; Woodhams B; Brohée D
    Am J Hematol; 2006 Jun; 81(6):414-9. PubMed ID: 16680742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble fibrin monomer degradation products as a potentially useful marker for hypercoagulable states with accelerated fibrinolysis.
    Ieko M; Nakabayashi T; Tarumi T; Naito S; Yoshida M; Kanazawa K; Mizukami K; Koike T
    Clin Chim Acta; 2007; 386(1-2):38-45. PubMed ID: 17803984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasma levels of soluble fibrin in patients with disseminated intravascular coagulation].
    Wada H; Takeda Y; Sakakura M; Watanabe R; Nakazaki T; Shiku H; Nishioka J; Nobori T
    Rinsho Byori; 2001 Aug; 49(8):813-7. PubMed ID: 11573293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma soluble fibrin monomer complex is a useful predictor of disseminated intravascular coagulation in neonatal sepsis.
    Selim TE; Ghoneim HR; Khashaba MT; Rakha SA
    Haematologica; 2005 Mar; 90(3):419-21. PubMed ID: 15749684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New clinical laboratory tests for hematological diseases].
    Matsuno K
    Nihon Naika Gakkai Zasshi; 2001 Nov; 90(11):2225-31. PubMed ID: 11769520
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study of hemostatic molecular marker].
    Wada H; Ioka M
    Rinsho Byori; 1997 Apr; 45(4):310-4. PubMed ID: 9136593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasma fibrin monitor level in DIC patients with a hematopoietic malignancy].
    Hiyoyama K; Wada H; Shimura M; Deguchi H; Nagaya S; Wakita Y; Deguchi K; Shiku H
    Rinsho Byori; 1996 Jan; 44(1):57-60. PubMed ID: 8691641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of molecular markers in hemostasis and thrombosis.
    Bick RL
    Semin Thromb Hemost; 1984 Oct; 10(4):290-3. PubMed ID: 6515423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blood coagulation tests in the diagnosis of acute disseminated intravascular coagulation with hyperfibrinolysis].
    Bomski H
    Pol Tyg Lek; 1982 Nov; 37(46-47):1411-4. PubMed ID: 7183995
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.